Ondine Biomedical Inc. (AIM:OBI)
London · Delayed Price · Currency is GBP · Price in GBX 9.75
0.00 (0.00%)
Sep 29, 2026, 5:15 PM GMT
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 50.66 million as of October 15, 2026. It is the 28,125th most valuable company in the world and the 621st biggest in the United Kingdom. Its market cap has decreased by 21.36% in one year.
Market Cap
50.66M
Enterprise Value
45.15M
Revenue
1.53M
Global Rank
Country Rank
#621 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 50.66M, a decrease of -55.12%. That is a compound annual growth rate of -15.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 50.66M | 30.32% |
| Dec 31, 2025 | 38.87M | 9.33% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
| Dec 6, 2021 | 112.86M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 113.56M |
| Bioventix | 95.09M |
| 4basebio | 87.40M |
| Faron Pharmaceuticals Oy | 75.59M |
| Poolbeg Pharma | 51.07M |
| Hemogenyx Pharmaceuticals | 49.23M |
| Sareum Holdings | 38.11M |
| Arecor Therapeutics | 33.98M |